Home > Boards > US OTC > Cannabis > Canbiola Inc. (CANB)

WHY I LIKE CANB

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sleekscape Member Profile
Member Level 
Followed By 850
Posts 27,205
Boards Moderated 3
Alias Born 03/16/14
160x600 placeholder
Canbiola Reports Third Quarter 2019 Results InvestorsHub NewsWire - 11/20/2019 8:20:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/19/2019 6:23:20 AM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 11/15/2019 4:31:11 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/14/2019 3:55:05 PM
Canbiola Creates Fully Independent Board of Directors InvestorsHub NewsWire - 10/15/2019 9:22:43 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 7:03:28 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/11/2019 9:39:37 AM
KALY - CBD Drug Patent BREAKOUT - 400% Run Potential From $0.01 To $0.04 InvestorsHub NewsWire - 8/21/2019 1:07:33 PM
Canbiola Reports Second Quarter 2019 Results InvestorsHub NewsWire - 8/20/2019 9:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/19/2019 10:18:17 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/14/2019 3:30:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2019 6:05:06 AM
Canbiola Launches Dedicated Canbiola-Branded CBD Dispensing Machine InvestorsHub NewsWire - 8/5/2019 9:30:49 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2019 7:25:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/2/2019 5:01:53 PM
Canbiola Appoints John Bach to its Corporate Advisory Board InvestorsHub NewsWire - 7/29/2019 9:30:00 AM
Canbiola Becomes Vertically Integrated with its Joint Venture with NY - SHI and Shi Farms InvestorsHub NewsWire - 7/22/2019 10:46:47 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/18/2019 4:34:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/18/2019 6:16:02 AM
Canbiola Presentation from Annual Shareholder Meeting is Publicly Available InvestorsHub NewsWire - 7/2/2019 11:15:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 7/1/2019 10:32:10 AM
sleekscape Member Level  Sunday, 11/17/19 07:19:55 PM
Re: None
Post # of 22566 
WHY I LIKE CANB

As the only publicly traded company in America producing and selling a full lineup of Pure CBD Oil products, as well as growing and processing hemp for CBD Isolate, CANB is best positioned to deliver a windfall to its investors in 2019-2020 due to the FDA permitting Pure CBD in dietary supplements to sell nationally

Mile High Labs and Medterra are two of the biggest CBD Isolate and Pure CBD product companies in America and both are wildly successful, but neither one is publicly traded, so where else can an investor gain exposure to CBD Isolate and Pure CBD products besides CANB?

Being the only CBD Oil stock in America utilizing the formulation of CBD most likely to be federally legalized by the FDA is certainly the most obvious advantage that CANB has over the rest of the sector:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152129318

But there are several other advantages that CANB possesses, and the following favorable factors are acting synergistically with CANB’s Pure CBD formulation to give it the greatest % gain potential from current prices in the CBD Oil sector:


1. Best financing in the sector


Private Placements at zero discount to market in August (restricted shares)

$4,000,000 raised at $.029

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152131404


2. Most rapid annual revenue growth in the sector


500% revenue growth year-over-year

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151962562


3. Only processor of raw hemp into CBD Isolate (as opposed to Full Spectrum CBD)


That is a unique advantage because CBD Isolate Processing is a huge market, there’s a tremendous lack of processors, and as has already been stated, Pure CBD is likely to be the only formulation to receive FDA approval for national sales

CANB is partnering with Mile High Labs for processing hemp

https://www.milehighlabs.com/


4. Complete vertical integration from seed to sale


CANB is also a grower of hemp as well, so they have achieved complete vertical integration and full control over the entire supply chain from seed to sale, thereby maximizing profit margins

CANB is partnering with Shi Farms for growing hemp

https://www.shifarms.com/


5. The depth and expertise of the corporate and medical advisory boards


8 MDs, 4 attorneys, 1 orthopedic surgeon and a Senator

https://canbiola.com/management-team/


6. Medical Sales


CANB sells to both the retail and medical markets, but they specialize in the sales of CBD Oil products to the medical & healthcare community, which is a far less crowded market


7. No convertible debt


Very rare on the OTC, as this is typically how these companies raise money


8. Potential to uplist to Nasdaq


Canbiola, Inc. (the “Company”) submitted an application to be listed on The Nasdaq Capital Market® on June 4, 2019. The Company intends to diligently pursue its application in order to have its securities listed on the Nasdaq Stock Market.

With a fully independent board of directors and the shareholder equity criteria now met, CANB now has the potential to uplist to the Nasdaq in 2020:

https://www.otcmarkets.com/filing/conv_pdf?id=13484913&guid=yRKSUW-VfXVyW3h


Sleek

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist